Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | HMGCR | P04035 | 1/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.39 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.39 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.39 |
| ▸ | CPT2 | P23786 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | ACLY | P53396 | 3/20 | 0.35 |
| ▸ | LDHA | P00338 | 1/20 | 0.33 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17102799 | 1.00 | ALDH1A1 (0.43) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL444254 | 1.00 | ALDH1A1 (0.43) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL1274984 | 1.00 | ALDH1A1 (0.43) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL41577 | 1.00 | ALDH1A1 (0.43) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Water SCHEMBL4943812 | 0.97 | ALDH1A1 (0.41) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Water SCHEMBL7071971 | 0.97 | ALDH1A1 (0.41) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL17215697 | 0.97 | ALDH1A1 (0.41) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Water SCHEMBL2300544 | 0.97 | ALDH1A1 (0.41) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Water SCHEMBL9621712 | 0.97 | ALDH1A1 (0.41) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL4652123 | 0.97 | ALDH1A1 (0.41) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026099342-A1 | ORAL CARE COMPOSITION FOR USE IN THE TREATMENT OF DRY MOUTH | ORAL CARE SOLUTIONS GMBH (CH) | 2026-05-15 | — | — | WO | claimed |
| EP-4740931-A1 | ORAL CARE COMPOSITION FOR USE IN THE TREATMENT OF DRY MOUTH | Oral Care Solutions GmbH (CH) | 2026-05-13 | — | — | EP | claimed |
| US-20250367170-A1 | TOPICAL ANGIOTENSIN II RECEPTOR BLOCKERS (ARBS) FOR TREATING EYE CONDITIONS | CLEVELAND CLINIC FOUND (US) | 2025-12-04 | — | — | US | claimed |
| US-12460192-B2 | Lipid-encapsulated dual-cleaving endonuclease for DNA and gene editing | SPECIFIC BIOLOGICS INC. (CA) | 2025-11-04 | — | — | US | claimed |
| US-12459904-B2 | Process for preparing carbamoyloxymethyl triazole cyclohexyl acid compounds | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-11-04 | — | — | US | claimed |
| EP-4638677-A1 | CONTACT LENS TREATING SOLUTION | Bausch + Lomb Ireland Limited (IE) | 2025-10-29 | — | — | EP | claimed |
| US-20250297238-A1 | LIPID-ENCAPSULATED DUAL-CLEAVING ENDONUCLEASE FOR DNA AND GENE EDITING | SPECIFIC BIOLOGICS INC. (CA) | 2025-09-25 | — | — | US | claimed |
| EP-4532017-A1 | TOPICAL ANGIOTENSIN II RECEPTOR BLOCKERS (ARBS) FOR TREATING EYE CONDITIONS | The Cleveland Clinic Foundation (US) | 2025-04-09 | — | — | EP | claimed |
| US-12163093-B2 | Chelating agents for barium sulfate dissolution in displacment spacer systems | BAKER HUGHES OILFIELD OPERATIONS LLC (US) | 2024-12-10 | — | — | US | claimed |
| US-20240350402-A1 | TOPICAL DRUG TREATMENT TO PREVENT OR REDUCE CORNEAL SCARRING | THE CLEVELAND CLINIC FOUNDATION | 2024-10-24 | — | — | US | claimed |
| EP-0350540-A1 | Composition for the maintenance of cars | BETA PICTORIS INC. (LR) | 1990-01-17 | — | — | EP | claimed |
| US-4814439-A | Chemical process for the denitration of nitrocellulose | THE UNITED STATES OF AMERICA AS REPESENTED BY THE SECRETARY OF THE ARMY (US) | 1989-03-21 | — | — | US | claimed |
| EP-0238551-A4 | METHODS FOR THE RECOVERY OF TISSUE PLASMINOGEN ACTIVATOR. | CODON (US) | 1988-02-01 | — | — | EP | claimed |
| EP-0238551-A1 | METHODS FOR THE RECOVERY OF TISSUE PLASMINOGEN ACTIVATOR | BERLEX LABORATORIES, INC. (US) | 1987-09-30 | — | — | EP | claimed |
| WO-1987001389-A1 | METHODS FOR THE RECOVERY OF TISSUE PLASMINOGEN ACTIVATOR | CODON (US) | 1987-03-12 | — | — | WO | claimed |
| EP-0115077-B1 | BLOOD DILUENT | Becton Dickinson and Company (US) | 1987-03-11 | — | — | EP | claimed |
| US-4200238-A | Method of preparing a rapidly soluble and machine handleable particulate composite and product | OWENS-ILLINOIS, INC. (US) | 1980-04-29 | — | — | US | claimed |
| US-4124542-A | AMMONIUM LAURYL SULFATE | OUTRIGHT INDUSTRIES, INC., A CORP. OF NV. | 1978-11-07 | — | — | US | claimed |
| US-3961087-A | Process for preparing cooked rice | AMERICAN FROZEN FOODS CORPORATION (US) | 1976-06-01 | — | — | US | claimed |
| US-3941723-A | Crystallized alkali metal silicate with sequestering agents | PHILADELPHIA QUARTZ COMPANY (US) | 1976-03-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12459904-B2 | Process for preparing carbamoyloxymethyl triazole cyclohexyl acid compounds | LPAR2, LPAR3, LPAR5 | ALDH1A1 3831/4885HMGCR 1892/4885CHRM1 391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.